Life AI Net
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
تسجيل الدخول
العربية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
تسجيل الدخول
الرئيسية
الأرشيف
الحاسبات
الدليل
More
مباشر
Pfizer
Pfizer gets a jump on Chai's new model, thanks to drug discovery pact - FirstWord Pharma
Endpoints News
Otsuka touts new IgAN evidence as it seeks full approval for Voyxact
Agilent
A Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - simplywall.st
Charles River
Charles River Laboratories stock (US1591881009): Insider grant and fresh fund buying keep focus on C - AD HOC NEWS
Endpoints News
Acting FDA chief isn't interested in permanent role
Clinical OMICs
Post-Stroke Arm Immobility Improved with Spinal Cord Stimulation
Lonza News
Stipple Bio and Lonza Agree to Focus on Advancing Oncology ADC Therapies - Genetic Engineering and Biotechnology News
Pfizer
Pfizer strikes $10.5 billion oncology deal with Chinese biotech - Life Sciences Intellectual Property Review
Clinical OMICs
Infant Brain Development Sheds Light on Parkinson’s Link with Autism
Clinical OMICs
Alzheimer’s Genetic Risk Loci: 16 New Candidates
Endpoints News
Acting FDA commissioner pledges to prevent political interference in rare disease meeting
Endpoints News
Dimension seeks up to $750M for third life sciences fund after string of success
Pfizer
Pfizer gets a jump on Chai's new model, thanks to drug discovery pact - FirstWord Pharma
Endpoints News
Otsuka touts new IgAN evidence as it seeks full approval for Voyxact
Agilent
A Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - simplywall.st
Charles River
Charles River Laboratories stock (US1591881009): Insider grant and fresh fund buying keep focus on C - AD HOC NEWS
Endpoints News
Acting FDA chief isn't interested in permanent role
Clinical OMICs
Post-Stroke Arm Immobility Improved with Spinal Cord Stimulation
Lonza News
Stipple Bio and Lonza Agree to Focus on Advancing Oncology ADC Therapies - Genetic Engineering and Biotechnology News
Pfizer
Pfizer strikes $10.5 billion oncology deal with Chinese biotech - Life Sciences Intellectual Property Review
Clinical OMICs
Infant Brain Development Sheds Light on Parkinson’s Link with Autism
Clinical OMICs
Alzheimer’s Genetic Risk Loci: 16 New Candidates
Endpoints News
Acting FDA commissioner pledges to prevent political interference in rare disease meeting
Endpoints News
Dimension seeks up to $750M for third life sciences fund after string of success
الأرشيف
هذا المقال غير متوفر في الأرشيف.